Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.-d.
Right arrow Articles by Hu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-d.
Right arrow Articles by Hu, X.
Clinical Cancer Research Vol. 10, 8380-8385, December 15, 2004
© 2004 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population

Yi-ding Chen1, Shu Zheng2, Jie-kai Yu2 and Xun Hu2

1 Department of Oncology, Second Affiliated Hospital, and 2 Cancer Institute, College of Medicine, Zhejiang University, HangZhou, Zhejiang, Peoples Republic of China

Purpose: The low specificity and sensitivity of the carcinoembryonic antigen test makes it not an ideal biomarker for the detection of colorectal cancer. We developed and evaluated a proteomic approach for the simultaneous detection and analysis of multiple proteins for distinguishing individuals with colorectal cancer from healthy individuals.

Experimental Design: We subjected serum samples (including 55 colorectal cancer patients and 92 age- and sex-matched healthy individuals) from 147 individuals, for analysis by surface-enhanced laser desorption/ionization (SELDI) mass spectrometry. Peaks were detected with Ciphergen SELDI software version 3.0. Using a multilayer artificial neural network with a back propagation algorithm, we developed a classifier for separating the colorectal cancer groups from the healthy groups.

Results: The artificial neural network classifier separated the colorectal cancer from the healthy samples, with a sensitivity of 91% and specificity of 93%. Four top-scored peaks, at m/z of 5,911, 8,930, 8,817, and 4,476, were finally selected as the potential "fingerprints" for detection of colorectal cancer.

Conclusions: The combination of SELDI-TOF mass spectrometry with the artificial neural networks in the analysis of serum protein yields significantly higher sensitivity and specificity values for the detection and diagnosis of colorectal cancer.




This article has been cited by other articles:


Home page
Cancer Genomics ProteomicsHome page
A. LEBRECHT, D. BOEHM, M. SCHMIDT, H. KOELBL, R. L. SCHWIRZ, and F. H. GRUS
Diagnosis of Breast Cancer by Tear Proteomic Pattern
Cancer Genomics Proteomics, May 1, 2009; 6(3): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
Brief BioinformHome page
L. J. Lancashire, C. Lemetre, and G. R. Ball
An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies
Brief Bioinform, May 1, 2009; 10(3): 315 - 329.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
A. LEBRECHT, D. BOEHM, M. SCHMIDT, H. KOELBL, and F. H. GRUS
Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum
Cancer Genomics Proteomics, March 1, 2009; 6(2): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. F. Ransohoff, C. Martin, W. S. Wiggins, B. A. Hitt, T. O. Keku, J. A. Galanko, and R. S. Sandler
Assessment of Serum Proteomics to Detect Large Colon Adenomas
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2188 - 2193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Hundt, U. Haug, and H. Brenner
Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1935 - 1953.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J.-x. Wang, P. Qin, Q.-l. Liu, H.-y. Yang, Y.-z. Fan, J.-k. Yu, and S. Zheng
Detection and Significance of Serum Protein Marker of Hirschsprung Disease
Pediatrics, July 1, 2007; 120(1): e56 - e60.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. Nedelkov, U. A. Kiernan, E. E. Niederkofler, K. A. Tubbs, and R. W. Nelson
Population Proteomics: The Concept, Attributes, and Potential for Cancer Biomarker Research
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1811 - 1818.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.